Aspect Analytics, a leading provider of software for spatial biology data analysis, today announced the successful closing of an oversubscribed € 10 million Series A funding round. The investment will accelerate the company’s international expansion, support continued innovation, and reinforce its position as the leader in spatial multi-omic data integration and large-scale research collaborations.
The announcement coincides with a strategic leadership transition. Marc Claesen, co-founder and former CEO, will assume the role of Chief Technology Officer, leveraging his deep expertise in spatial biology, machine learning, and artificial intelligence to drive the company’s AI-powered analytical capabilities. Steven Verhoeven will take on the role of Chief Executive Officer, bringing extensive experience in scaling VC- and PE-backed life sciences and diagnostics companies globally.
A Unique Approach to Spatial Biology
Aspect Analytics provides a patented software platform that enables researchers to integrate data from multiple spatial technologies, delivering true multi-omics insights. The Weave platform is uniquely capable of analyzing data at scale and deciphering complex multicellular environments, providing pharmaceutical and academic researchers with critical insights to uncover novel targets, unravel drug mechanisms of action, and optimize clinical trial cohorts.
Fueling Growth and Global Expansion
The Series A funding will support Aspect Analytics’ international expansion, continued product innovation, and delivery of unique, industry-leading capabilities to its customers. The round was led by PMV and Capricorn Partners, through their Capricorn Healthtech Fund II, alongside existing shareholders and management. Existing investors include Heran Partners, Gemma Frisius Fund and KU Leuven.
For further reading, please go to Capricorn’s website.